An invalid vocabulary is selected. Please change it in the options.
Title Credits Start date - Expiration datesort ascending
The Impact of Frontline Immune Checkpoint Inhibitors on Therapy for Relapsed/Refractory Hodgkin Lymphoma 0.75 06/15/2025 - 12:00am to 03/01/2026 - 12:00am
Smoking Cessation for Patients with Cancer: State of the Evidence 1.00 06/15/2025 - 12:00am to 03/01/2026 - 12:00am
Team-Based Case Review: Oligometastatic Prostate, Non-Small Cell Lung, and Colorectal Cancers 1.00 06/15/2025 - 12:00am to 03/01/2026 - 12:00am
Newer Approaches to Treatment of Bladder Cancer 1.00 06/15/2025 - 12:00am to 03/01/2026 - 12:00am
Management of Immune Checkpoint Inhibitor-Related Toxicities 1.00 06/15/2025 - 12:00am to 03/01/2026 - 12:00am
Advances in the Treatment of Non-Metastatic Non-Small Cell Lung Cancer 1.00 06/15/2025 - 12:00am to 03/01/2026 - 12:00am
Best Practices for Oncology Urgent Care 1.00 06/15/2025 - 12:00am to 03/01/2026 - 12:00am
Treatment for Pleural and Peritoneal Mesothelioma 0.75 06/15/2025 - 12:00am to 03/01/2026 - 12:00am
Updates in Metastatic Colorectal Cancer 0.75 06/15/2025 - 12:00am to 03/01/2026 - 12:00am
NCCN Guidelines® Insights - Survivorship, Version 2.2025 1.00 06/10/2025 - 12:00am to 06/10/2026 - 12:00am
Archived NCCN Tumor Boards: Treatment Options and Navigating Sequencing of Therapies in Relapsed/Refractory Multiple Myeloma 1.00 05/28/2025 - 12:00am to 05/23/2026 - 11:59pm
Archived NCCN Tumor Boards: New Approaches to the Management of Resectable Non-Small Cell Lung Cancer 1.00 05/28/2025 - 12:00am to 05/22/2026 - 11:59pm
Recorded Presentation from Optimizing Patient Outcomes - Targeted Therapies for Thyroid Carcinoma 1.00 05/27/2025 - 12:00am to 05/27/2026 - 12:00am
NCCN Guidelines® Insights - Multiple Myeloma, Version 1.2025 1.00 05/10/2025 - 12:00am to 05/10/2026 - 12:00am
Archived NCCN Tumor Boards: T-Cell Engager Therapy for Diffuse Large B-Cell Lymphoma: Bispecific Antibodies for Relapsed/Refractory Disease 1.00 05/06/2025 - 12:00am to 04/30/2026 - 12:00am

Pages